FDA Inspection 709502 — Immunostics, Inc.

Immunostics, Inc. — FEI 2244821

The FDA completed an inspection of Immunostics, Inc. on Feb 18, 2011 in Eatontown, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). 5 citations were issued during this inspection. Product area: Devices.

Inspection details

Classification
No Action Indicated (NAI)
End Date
Feb 18, 2011
Fiscal Year
2011
Product Type
Devices
Project Area
Postmarket Assurance: Devices
Location
Eatontown, NJ (United States)

Citations

IDCFRDescription
312021 CFR 820.80(a)Lack of or inadequate procedures - Acceptance activities
315921 CFR 820.184DHR content
317221 CFR 820.198(c)Investigation of device failures
328221 CFR 820.90(a)Nonconforming product, Lack of or inadequate procedures
342521 CFR 820.50(a)(1)Evaluation and Selection, Suppliers, Contractors, etc.

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.